TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages
Open Access
Abstract
Triggering receptor expressed on myeloid cell 2 (TREM2), a myeloid cell‐specific signaling molecule, controls essential functions of microglia and impacts on the pathogenesis of Alzheimer's disease and other neurodegenerative disorders. TREM2 is also highly expressed in tumor‐associated macrophages in different types of cancer. Here, we studied whether TREM2 influences glioma progression. We found a gender‐dependent effect of glioma growth in wild‐type (WT) animals injected with GL261‐EGFP glioma cells. Most importantly, TREM2 promotes glioma progression in male but not female animals. The accumulation of glioma‐associated microglia/macrophages (GAMs) and CD31+ blood vessel density is reduced in male TREM2‐deficient mice. A transcriptomic analysis of glioma tissue revealed that TREM2 deficiency suppresses immune‐related genes. In an organotypic slice model devoid of functional vascularization and immune components from periphery, the tumor size was not affected by TREM2‐deficiency. In human resection samples from glioblastoma, TREM2 is upregulated in GAMs. Based on the Cancer Genome Atlas Program (TCGA) and the Chinese Glioma Genome Atlas (CGGA) databases, the TREM2 expression levels were negatively correlated with survival. Thus, the TREM2‐dependent crosstalk between GAMs and the vasculature formation promotes glioma growth.Keywords
Funding Information
- China Postdoctoral Science Foundation (2022TQ0356)
This publication has 64 references indexed in Scilit:
- Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasionActa Biochimica et Biophysica Sinica, 2015
- Glioma-derived versican promotes tumor expansion via glioma-associated microglial/macrophages Toll-like receptor 2 signalingNeuro-Oncology, 2014
- CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironmentCarcinogenesis, 2014
- Changing incidence and improved survival of gliomasEuropean Journal of Cancer, 2014
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosisScience Translational Medicine, 2014
- Angiogenic properties of the chemokine RANTES/CCL5Biochemical Society Transactions, 2011
- Vessel abnormalization: another hallmark of cancer?Current Opinion in Genetics & Development, 2011
- A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microgliaJournal of Neurochemistry, 2009
- IntegrinsArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- TREMs in the immune system and beyondNature Reviews Immunology, 2003